Inizio appoints Ryan Quigley as CEO to lead next phase of growth

Ryan Quigley appointed CEO to lead Inizio’s next growth chapter 

We are delighted to announce the appointment of Ryan Quigley as Chief Executive Officer, effective 9 September 2025. Paul Taaffe will remain closely involved with Inizio as an Advisor and board member going forward. 

Ryan has served as Chief Operating Officer since 2021, driving the company’s commercial strategy, innovation agenda, and investment roadmap, and playing a pivotal role in developing Inizio into the leading commercialization partner to health and life sciences companies globally.   

A proven leader with deep healthcare and life sciences expertise 

Before being appointed to his current role, Ryan’s career spans 25 years working across some of the world’s largest healthcare and pharmaceutical companies. Most notably, he held senior leadership roles at Abbott and AbbVie, where he was responsible for launching blockbuster brands across major markets.   

“This is an exciting time to lead Inizio as we continue to grow and help biopharma clients with integrated solutions to bring highly complex new drugs to market. At Inizio, it’s the combination of our people and our expertise that makes the difference: we connect talent from across the organization to create innovative solutions that make a meaningful difference for our clients and patients. Together, we will continue to unlock new opportunities, reimagine how healthcare engages with patients, professionals and society, and build on the momentum we have achieved over the last few years.” – Ryan Quigley, CEO, Inizio

“Ryan has an exceptional track record as a leader who combines strategic vision with deep operational expertise. He embodies the values of Inizio and has the energy, ambition and client focus to lead the business into its next chapter of growth and success. I would like to thank Paul personally and on behalf of the Board of Directors for his contribution to the successful development of Inizio as its CEO. He oversaw the creation of the company and built a market leader well positioned for sustained growth. Paul will remain closely involved with Inizio as a board member going forward.” – Liam FitzGerald, Chairman of the Board, Inizio 

Inizio’s continued commitment to innovation and healthcare impact 

This transition marks an important moment in our journey, and we are grateful to Paul for his exceptional leadership and the strong foundation he has built. Ryan has been an incredible force in guiding our strategy and growth, and we couldn’t be more confident in his leadership as we look to the future. Together with our clients and partners, we remain committed to navigating complexity, accelerating innovation, and making a meaningful impact in healthcare. Get in touch to learn more.